Perkins Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Perkins Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$142K	Hold	10,300	–	–	﹤0.01%	247
2016 Q4	$182K	Buy	+10,300	New	+$181K	﹤0.01%	247
2015 Q3	–	Sell	-17,100	Closed	-$319K	–	268
2015 Q2	$319K	Buy	17,100 +600	+4%	+$11.1K	﹤0.01%	242
2015 Q1	$315K	Sell	16,500 -34,116	-67%	-$631K	﹤0.01%	251
2014 Q4	$833K	Sell	50,616 -492,552	-91%	-$8.45M	0.01%	247
2014 Q3	$9.61M	Sell	543,168 -699,885	-56%	-$13.8M	0.09%	176
2014 Q2	$25.7M	Buy	1,243,053 +414,143	+50%	+$8.51M	0.21%	120
2014 Q1	$18.1M	Buy	+828,910	New	+$19M	0.14%	142
2013 Q3	–	Sell	-10,500	Closed	-$226K	–	291
2013 Q2	$226K	Buy	+10,500	New	+$226K	﹤0.01%	272

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Perkins Investment Management's VIVO Position: Q1 2017 in Review

Perkins Investment Management held its Meridian Bioscience Inc (VIVO) position steady in Q1 2017 at 10,300 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Perkins Investment Management first reported a position in VIVO in Q2 2013 and has held it in 9 quarters since. The position peaked at $25.7M in Q2 2014. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

Perkins Investment Management held 10,300 shares of Meridian Bioscience Inc worth $142K as of Q1 2017.
Perkins Investment Management left its Meridian Bioscience Inc share count unchanged in Q1 2017.
Meridian Bioscience Inc made up ﹤0.01% of Perkins Investment Management's portfolio in Q1 2017, its #247 holding.
Perkins Investment Management first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 9 quarters since.
Perkins Investment Management's Meridian Bioscience Inc position peaked at $25.7M in Q2 2014.
165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.